These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6200866)

  • 1. In vitro, release of cholecystokinin from hypothalamus and frontal cortex of Sprague-Dawley, Zucker lean (Fa/-) and obese (fa/fa) rats.
    Micevych PE; Go VL; Yaksh TL; Finkelstein J
    Peptides; 1984; 5(1):73-80. PubMed ID: 6200866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of opiates on the release of cholecystokinin from in vitro hypothalamus and frontal cortex of Zucker lean (Fa/-) and obese (fa/fa) rats.
    Micevych PE; Yaksh TL; Go VW; Finkelstein JA
    Brain Res; 1985 Jul; 337(2):382-5. PubMed ID: 3896389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lean (Fa/Fa) but not obese (fa/fa) Zucker rats release cholecystokinin at PVN after a gavaged meal.
    De Fanti BA; Backus RC; Hamilton JS; Gietzen DW; Horwitz BA
    Am J Physiol; 1998 Jul; 275(1):E1-5. PubMed ID: 9688866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meal-stimulated increased concentrations of CCK in the hypothalamus of Zucker obese and lean rats.
    McLaughlin CL; Baile CA; Della-Fera MA; Kasser TG
    Physiol Behav; 1985 Aug; 35(2):215-20. PubMed ID: 4070386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal polypeptide (VIP) inhibits potassium-induced release of cholecystokinin (CCK) from rat caudato-putamen but not from cerebral cortex.
    Allard LR; Beinfeld MC
    Neuropeptides; 1986 Oct; 8(3):287-93. PubMed ID: 3785588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin, bombesin and neurotensin in brain tissue from obese animals.
    Oku J; Inoue S; Glick Z; Bray GA; Walsh JH
    Int J Obes; 1984; 8(2):171-82. PubMed ID: 6724799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord.
    Yaksh TL; Abay EO; Go VL
    Brain Res; 1982 Jun; 242(2):279-90. PubMed ID: 6896838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meal-induced changes in extracellular 5-HT in medial hypothalamus of lean (Fa/Fa) and obese (fa/fa) Zucker rats.
    De Fanti BA; Hamilton JS; Horwitz BA
    Brain Res; 2001 Jun; 902(2):164-70. PubMed ID: 11384609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin binding in the hypothalamus of lean and genetically obese Zucker rats.
    Wilcox BJ; Corp ES; Dorsa DM; Figlewicz DP; Greenwood MR; Woods SC; Baskin DG
    Peptides; 1989; 10(6):1159-64. PubMed ID: 2622801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin receptor binding levels in the genetically obese rat brain.
    Finkelstein JA; Steggles AW; Martinez PA; Praissman M
    Peptides; 1984; 5(1):11-4. PubMed ID: 6324145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of vasoactive intestinal polypeptide (VIP)- and cholecystokinin (CCK)-like immunoreactivities in thalamocortical neuron in the ventrolateral nucleus of the rat.
    Ogawa R; Itoh K; Kaneko T; Mizuno N
    Brain Res; 1989 Jun; 490(1):152-6. PubMed ID: 2758323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
    Wang JY; Yaksh TL; Go VL
    Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic regulatory peptides in obese and lean Zucker rats.
    Williams G; Cardoso HM; Lee YC; Ball JM; Ghatei MA; Stock MJ; Bloom SR
    Clin Sci (Lond); 1991 May; 80(5):419-26. PubMed ID: 1709601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 24-hour variation in content and release of hypothalamic neuropeptides in the rat.
    Nicholson SA; Adrian TE; Bacarese-Hamilton AJ; Gillham B; Jones MT; Bloom SR
    Regul Pept; 1983 Dec; 7(4):385-97. PubMed ID: 6199815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical analysis of somatostatin in the hypothalamus of obese and non-obese Zucker rats.
    DonCarlos LL; Ho RH; Finkelstein JA
    Brain Res; 1988 Aug; 458(2):372-6. PubMed ID: 2905199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased pancreatic exocrine response to cholecystokinin in Zucker obese rats.
    McLaughlin CL; Peikin SR; Baile CA
    Am J Physiol; 1982 Jun; 242(6):G612-9. PubMed ID: 6178298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate-mediated inhibition of the release of cholecystokinin and substance P, but not neurotensin from cat hypothalamic slices.
    Micevych PE; Yaksh TL; Go VL
    Brain Res; 1982 Nov; 250(2):283-9. PubMed ID: 6184121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal and glucoprivic-induced changes in extracellular GABA in the ventral hypothalamus of Zucker rats.
    Specter SE; Horwitz BA; Beverly JL
    Am J Physiol; 1996 Aug; 271(2 Pt 2):R388-92. PubMed ID: 8770139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in brain CCK concentrations with peripheral CCK injections in Zucker rats.
    McLaughlin CL; Baile CA; Della-Fera MA
    Physiol Behav; 1986; 36(3):477-82. PubMed ID: 3703977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.